Symbol | Börsvärde | Pris | Förändring % | Volym | Rel Volume | P/E-tal | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sektor | Analytisk bedömning |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 607.992 T ARS | 13690.000 ARS | −0.75% | 334 | 0.21 | — | — | — | — | Health Technology | — |
LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 607.992 T ARS | 13.200 USD | 0.00% | 14 | 0.15 | — | — | — | — | Health Technology | — |
JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 312.598 T ARS | 10370.000 ARS | −1.05% | 3.876 K | 0.30 | 42.69 | 242.90 ARS | +459.57% | 0.87% | Health Technology | — |
DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 312.598 T ARS | 1153.000 ARS | −0.60% | 10 | 0.00 | — | — | — | — | Health Technology | — |
JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 312.598 T ARS | 10.300 USD | −1.44% | 65 | 0.11 | 36.31 | 242.90 ARS | +48.88% | 0.87% | Health Technology | — |
MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 280.913 T ARS | 27534.500 ARS | +2.28% | 21.236 K | 33.98 | — | — | — | — | Health Technology | — |
MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 280.913 T ARS | 27.500 USD | +1.29% | 1 | 0.11 | — | — | — | — | Health Technology | — |
ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 259.489 T ARS | 17700.000 ARS | +0.01% | 20.965 K | 11.24 | 22.05 | 802.79 ARS | −6.12% | 1.00% | Health Technology | — |
ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 259.489 T ARS | 17.200 USD | −1.71% | 12 | 0.13 | 17.32 | 802.79 ARS | −77.92% | 1.00% | Health Technology | — |
AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 191.459 T ARS | 40150.000 ARS | +7.07% | 748 | 0.78 | 193.05 | 207.98 ARS | +257.80% | 1.13% | Health Technology | — |
AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 191.459 T ARS | 39.300 USD | +6.94% | 4 | 0.62 | 152.76 | 207.98 ARS | −15.86% | 1.13% | Health Technology | — |
NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 168.332 T ARS | 26001.000 ARS | +0.39% | 15 | 0.19 | — | — | — | — | Health Technology | — |
NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 168.332 T ARS | 24.250 USD | +4.98% | 2 | 0.34 | — | — | — | — | Health Technology | — |
PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 129.555 T ARS | 6757.000 ARS | −2.55% | 3.064 K | 0.13 | — | — | — | — | Health Technology | — |
PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 129.555 T ARS | 6.690 USD | −3.74% | 316 | 0.46 | — | — | — | — | Health Technology | — |
AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 127.783 T ARS | 9488.500 ARS | −1.38% | 63.243 K | 61.95 | — | — | — | — | Health Technology | — |
AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 127.783 T ARS | 9.950 USD | +1.74% | 31 | 0.53 | — | — | — | — | Health Technology | — |
BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 86.487 T ARS | 15910.500 ARS | −7.49% | 0.999 K | 2.57 | — | — | — | — | Health Technology | — |
BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 86.487 T ARS | 17.000 USD | −2.86% | 6 | 1.20 | — | — | — | — | Health Technology | — |
GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 73.35 T ARS | 10825.500 ARS | +0.19% | 2 | 0.01 | 55.71 | 194.30 ARS | −31.41% | 1.37% | Health Technology | — |
GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 73.35 T ARS | 10.300 USD | +0.98% | 7 | 0.24 | 42.85 | 194.30 ARS | −83.87% | 1.37% | Health Technology | — |
BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 25.643 T ARS | 16240.500 ARS | −1.41% | 9.034 K | 18.46 | — | — | — | — | Health Technology | — |
BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 25.643 T ARS | 16.250 USD | −18.75% | 20 | 2.47 | — | — | — | — | Health Technology | — |
RICHLABORATORIOS RICHMOND SACIF | 69.971 B ARS | 884.000 ARS | +2.02% | 250 | 0.05 | — | −130.78 ARS | — | 0.00% | Health Technology | — |
ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 3.896 B ARS | 91.500 ARS | 0.00% | 200 | 0.05 | — | — | — | 0.00% | Health Technology | — |